๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
By invitation
Hypofractionated Radiotherapy for HNSCC in Elderly Patients
NCT06768125Head and Neck Cancer Squamous Cell Carcinoma, ELDERLY PEOPLE, Hypofractionation
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not applicable
51
Beijing
2024-01-01
Recruiting
Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML
NCT06221683AML, Childhood, Acute Myeloid Leukemia
Children's Hospital of Soochow University
Phase 2
500
Hefei, Guangzhou, Nanning, Kaifeng, Zhengzhou, Changsha, Suzhou, Xuzhou
2024-01-01
Recruiting
Ultrasound-Guided Curved Needle Thread Carpal Tunnel Release: Efficacy and Safety of a Single-Center, Single-Arm Clinical Trial
NCT06440070Carpal Tunnel Syndrome
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
69
Guangzhou
2024-01-01
Recruiting
AI Detection of Bladder Tumors Under Endoscopy
NCT06474338Bladder Tumor
Peking Union Medical College Hospital
Observational
1,000
Beijing
2024-01-01
Recruiting
LivQ-boxยฎ Parameters in the Diagnosis of Liver Inflammation
NCT06802731Liver Inflammation, Fatty Liver Disease
Wuxi Hisky Medical Technology Co Ltd
Observational
365
Beijing
2024-01-01
Not yet open
Clinical Value of DWI-ADC Matching in the Short-term Prognosis of Wilson's Disease
NCT06196931Hepatolenticular Degeneration; Wilson
Hospital Affiliated to the Institute of Neurology, Anhui University of Chinese Medicine
Observational
200
Hefei
2024-01-01
Recruiting
Bariatric Surgery Combined With GLP-1 Receptor Agonists Study
NCT07336862Obesity
China-Japan Friendship Hospital
Phase 1/2
200
Beijing
2024-01-01
Recruiting
The Intelligent Prevention And Control System And Strategy For The Whole Disease Cycle Of Diabetic Nephropathy
NCT06843304Diabetic Nephropathy, T2DM
Chinese PLA General Hospital
Observational
2,000
Beijing
2024-01-01
Recruiting
Adebrelimab Injection (PD-L1) Combined With Short Course Radiotherapy and Chemotherapy for Neoadjuvant Therapy of Locally Advanced Rectal Cancer
NCT06765616Rectal Cancer, Advanced Stage Colorectal Cancer, Radiotherapy
Feng Tian
Phase 2
31
Jinan
2024-01-01
Recruiting
The Prognostic Value of the Degree of Pathological Response of Induction Chemotherapy for NPC
NCT06182657Nasopharyngeal Carcinoma, Pathologic Complete Response, Tumor Microenvironment
Jiangxi Provincial Cancer Hospital
Observational
300
Nanchang
2024-01-01
Recruiting
The Development and Validation of MRI-AI-based Predictive Models for csPCa
NCT06842264Prostate Cancer
Peking University First Hospital
Observational
3,000
Beijing
2024-01-01
Recruiting
Safety and Efficacy Study of Betaine Hydrochloride in Treating Hypergastrinemia in Patients With Autoimmune Gastritis
NCT06272500Autoimmune Gastritis
Jianning Yao
Not applicable
60
Zhengzhou
2024-01-01
Recruiting
The Effects of Immunonutrition Therapy on Locally Advanced Cervical Cancer Patients
NCT06349148Cervical Cancers
SHUANG ZHENG JIA, PhD
Not applicable
50
Beijing
2024-01-01
Not yet open
Intraoperative Radiotherapy in Treating Spinal Metastases
NCT06093854Spinal Metastases
Shanghai Changzheng Hospital
Not applicable
132
Shanghai
2024-01
Not yet open
Golidocitinib in Combination With Sintilimab for PD-L1 Selected Treatment Locally Advanced or Metastatic Non-Small Cell Lung Cancer(NSCLC)
NCT06198907Non-Small-Cell Lung Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
69
Beijing
2024-01
Not yet open
Effects and Safety of Clonidine Patch on Young and Middle-aged Smokers With Mild Hypertension
NCT05416840Hypertension
Jing Liu
Phase 4
92
Beijing
2024-01
Recruiting
Multi-modality Echocardiography for Cardiac Assessment in Primary Electrical Disease
NCT06172842Multi-modality Echocardiography, Primary Electrical Disease
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
30
Guangzhou
2024-01
Recruiting
A Clinical Study of [177Lu]Lu-XT117 Injection in Patients With Advanced Solid Tumors
NCT06211647Advanced Solid Tumor
Ruimin Wang
Phase 1
20
Beijing
2024-01
Recruiting
A Clinical Study of [177Lu]Lu-XT117 Injection in Patients With Advanced Solid Tumors
NCT06197139Advanced Solid Tumor
Xinlu Wang
Phase 1
20
Guangzhou
2024-01
Not yet open
Clinical Study of Short-course Radiotherapy Followed by Fruquintinib Plus Sintilimab vs Bevacizumab Plus Capecitabine as First Line Treatment in Advanced mCRC
NCT06195670CRC, Metastatic Colorectal Cancer, Metastatic Colorectal Adenocarcinoma
Zhejiang Cancer Hospital
Phase 1/2
220
Hangzhou
2024-01
Not yet open
Preemptive TIPS for Variceal Bleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis
NCT06122753Portal Hypertension, Portal Vein Thrombosis, Esophageal Varix Bleeding, Portosystemic Shunt
West China Hospital
Not applicable
120
Chengdu
2024-01
Not yet open
Study of Personalized Tumour Vaccines and a PD-L1 Blocker in Patients With Surgically Resected Pancreatic Adenocarcino
NCT06156267Pancreatic Cancer
Fudan University
Phase EARLY_PHASE1
30
Shanghai
2024-01
Recruiting
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)
NCT06136624Prostate Cancer Metastatic
Merck Sharp & Dohme LLC
Phase 3
1,310
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Guangzhou, Wuhan, Changsha
2023-12-31
Active, closed
A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in Participants With Essential Thrombocythemia and an Inadequate Response or Intolerance of Hydroxyurea (MK-3543-006)
NCT06079879Essential Thrombocythemia
Merck Sharp & Dohme LLC
Phase 3
340
Bengbu, Hefei, Beijing, Quanzhou, Xiamen, Guangzhou, Shijiazhuang, Zhengzhou
2023-12-31
Recruiting
Clinical Efficacy and Population Pharmacokinetics of ฮฒ-lactams in Cirrhotic Patients
NCT07612163Bacterial Infections
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Observational
1,000
Nanjing
2023-12-31
Recruiting
Chinese PICU Collaborative Network on Pathogens and Drug Resistance of Severe Infections
NCT04923828Severe Infection
Children's Hospital of Fudan University
Observational
2,000
Shanghai
2023-12-31
Recruiting
Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/Refractory B Cell Lymphoma
NCT06180174B Cell Lymphoma, Non Hodgkin Lymphoma
Chongqing Precision Biotech Co., Ltd
Phase 1
24
Beijing
2023-12-31
Recruiting
The Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLC
NCT06109558Non Small Cell Lung Cancer, RET Gene Mutation, MET Amplification, EGF-R Positive Non-Small Cell Lung Cancer
Hunan Province Tumor Hospital
Phase 1/2
120
Changsha
2023-12-31
Recruiting
To Assess the Efficacy and Safety of Furmonertinib in Patients With Epidermal Growth Factor Receptor 20ins Mutation Positive Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy
NCT06192849Non Small Cell Lung Cancer, EGFR Exon 20 Insertion Mutation
Juan LI, MD
Phase 2
20
Chengdu
2023-12-31
Recruiting
Treatment of Acute Ischemic StroKe With Intravenous UroKinase Real-world Research: a Multicenter, Prospective Study
NCT06194968Acute Ischemic Stroke
The First Affiliated Hospital of Zhengzhou University
Observational
1,800
Lanzhou, Zhanjiang, Beiliu, Guidong, Wuzhou, Yulin, Sanya, Jiamusi
2023-12-30
Not yet open
Effects of CBT-Based Intervention Among Patients With Liver Cancer
NCT05942560Depression, Anxiety, Liver Cancer, CBT
The Nethersole School of Nursing
Not applicable
160
Zhuhai
2023-12-30
Recruiting
HAIC, Lenvatinib, and Cadonilimab as Conversion Therapy for Initially Unresectable Hepatocellular Carcinoma
NCT06187961Hepatocellular Carcinoma Non-resectable
Tongji Hospital
Phase 2
36
Wuhan
2023-12-30
Recruiting
Doxorubicin Hydrochloride Liposome Combined With Irinotecan (AI Regimen) Versus VIT Regimen in the Treatment of Relapsed and Refractory Pediatric Rhabdomyosarcoma: a Prospective, Open-label, Randomized Controlled, Multicenter, Phase II Clinical Study
NCT05457829Rhabdomyosarcoma, Child
Sun Yat-sen University
Phase 2
88
Guangzhou
2023-12-30
Recruiting
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer
NCT05950945Breast Cancer
Daiichi Sankyo
Phase 3
250
Beijing, Fujian, Guangzhou, Hangzhou, Hefei, Jinan, Kunming, Nanchang
2023-12-30
Recruiting
Elderly Patients Undergoing Surgery During Perioperative Period
NCT07314762Postoperative Complications, Elderly, Postoperative Delirium (POD), Risk Prediction Model
Second Affiliated Hospital of Wenzhou Medical University
Observational
1,200
Wenzhou
2023-12-30
Recruiting
Application of Al18F-NOTA-Pentixafor PET/CT for Primary Aldosteronism
NCT06773663Primary Aldosteronism, Primary Aldosteronism Due to Aldosterone Producing Adenoma
Peking Union Medical College Hospital
Phase 1/2
150
Beijing
2023-12-30
Recruiting
A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease
NCT06189495Systemic Sclerosis Associated Interstitial Lung Disease, Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD), Systemic Sclerosis Associated Interstitial Lung Disease (SSc-ILD)
Changchun GeneScience Pharmaceutical Co., Ltd.
Phase 2
30
Beijing, Wuhan, Jinan, Chengdu
2023-12-30
Recruiting
Off-the-shelf CD123 CAR-NK for R/R AML
NCT06201247Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory
Peking University People's Hospital
Phase EARLY_PHASE1
12
Beijing
2023-12-30
Active, closed
Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasilยฎ9 in Young Women
NCT06197802Cervical Cancer, Condylomata Acuminata
Xiamen University
Observational
392
Nanjing
2023-12-30
Recruiting
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas
NCT06090539Relapsed/Refractory Non-Hodgkin Lymphoma
Bristol-Myers Squibb
Phase 1/2
460
Beijing, Guangzhou, Zhengzhou, Suzhou, Nanchang, Shenyang, Shanghai, Hangzhou
2023-12-29
Recruiting
A Study With Central Nervous System Metastatic EGFR Mutation Positive Non-small Cell Lung Cancer
NCT05991193NSCLC
Hunan Province Tumor Hospital
Observational
100
Changsha
2023-12-29
Active, closed
Multi-parametric Ultrasound Versus Multi-parametric MRI for Prostate Cancer Detection
NCT06183905PROSTATE CANCER, Prostate Biopsy
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
635
Shanghai
2023-12-29
Recruiting
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
NCT06137118B-cell Acute Lymphoblastic Leukemia (B-ALL)
AstraZeneca
Phase 1/2
255
Changsha, Chengdu, Guangzhou, Hangzhou, Nanjing, Suzhou, Tianjin, Zhengzhou
2023-12-29
Recruiting
A Study to Evaluate 9MW2821 Versus Chemotherapy in Subjects With Previously Treated Locally Advanced or Metastatic Urothelial Cancer
NCT06196736Advanced Urothelial Carcinoma
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 3
432
Shanghai
2023-12-29
Recruiting
A Phase III Clinical Study Comparing JS004 Plus Toripalimab With Investigator-Selected Chemotherapy in Patients With PD-(L)1monoclonal Antibody Refractory Classic Hodgkin Lymphoma (cHL)
NCT06170489Hodgkin Lymphoma
Shanghai Junshi Bioscience Co., Ltd.
Phase 3
185
Beijing
2023-12-28
Recruiting
a PROspective Case Control Study to Develop and Validate a Blood Test FOr mUlti-caNcers Early Detection๏ผˆPROFOUND๏ผ‰
NCT06217900Cancer
Shanghai Weihe Medical Laboratory Co., Ltd.
Observational
16,666
Beijing, Changchun, Guangzhou, Hangzhou, Shenyang
2023-12-28
Not yet open
Relmacabtagene Autoleucel in Hematologic Malignancies
NCT06142188Lymphoma, B-Cell, Large B-cell Lymphoma, Follicular Lymphoma
Shanghai Ming Ju Biotechnology Co., Ltd.
Observational
150
Beijing
2023-12-28
Recruiting
Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP)
NCT06168851Immune Thrombocytopenia, Treatment
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
60
Tianjin
2023-12-28
Recruiting
Exploration of Therapeutic Strategies for NeoRAS Wild-type Metastatic Colorectal Cancer Based on Circulating Tumor DNA
NCT06440902Colorectal Cancer Metastatic
Fudan University
Phase 2
1,100
Shanghai
2023-12-28
Recruiting
The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma
NCT06220552Recurrent Glioblastoma
Fifth Affiliated Hospital, Sun Yat-Sen University
Phase 2
20
Zhuhai
2023-12-27
Recruiting
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NCT06059638Hypertension, Hypertension, Systolic, Hypertension, Essential
Orchestra BioMed, Inc
Not applicable
316
Nanjing
2023-12-27
By invitation
A Study to Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic Dermatitis
NCT06158490Moderate-to-severe Atopic Dermatitis
Guangzhou JOYO Pharma Co., Ltd
Phase 2
120
Shanghai
2023-12-27
Recruiting
An Early Clinical Study Evaluating the Safety and Efficacy of AcNK-Sup003 Cell Injection in the Treatment of Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
NCT06693973B-cell Non-Hodgkin Lymphoma (B-NHL)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase EARLY_PHASE1
13
Wuhan
2023-12-27
Active, closed
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
NCT06141486Multiple Sclerosis
Sanofi
Phase 3
943
Beijing, Changchun, Changsha, Chengdu, Fuzhou, Guangzhou, Harbin, Jiazhuang
2023-12-27
Recruiting
The Efficacy and Safety of the COMBO Endoscopy Oropharyngeal Airway in Gastrointestinal Endoscopy Procedure
NCT06081647Hypoxia, Gastric Polyp, Colon Cancer, Esophageal Cancer
RenJi Hospital
Not applicable
1,200
Nanjing, Nanchang, Jinan, Shanghai, Xiโ€™an, Tianjin, Hangzhou
2023-12-27
Recruiting
A Study of GC012F in Patients With Relapsed/Refractory Multiple Myeloma
NCT06235229Multiple Myeloma
Gracell Biotechnologies (Shanghai) Co., Ltd.
Phase 1/2
110
Beijing, Hangzhou, Jinan, Shanghai, Shenyang, Wenzhou, Wuhan, Xi'an
2023-12-26
By invitation
The Safety and Efficacy of SNC-109 CAR-T Cells Therapy the rGBM
NCT06616727Recurrent Glioblastoma Multiforme (GBM)
Shanghai Simnova Biotechnology Co.,Ltd.
Phase 1
50
Beijing
2023-12-26
Recruiting
A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B
NCT06263959Chronic Hepatitis B
Fujian Akeylink Biotechnology Co., Ltd.
Phase 2
45
Beijing
2023-12-26
Recruiting
FOLFOX-HAIC Plus Lenvatinib and Toripalimab vs. FOLFOX-HAIC Plus Lenvatinib for Advanced Hepatocellular Carcinoma: a Randomized Controlled and Double-blind Trial
NCT06201065Hepatocellular Carcinoma
Sun Yat-sen University
Phase 3
200
Guangzhou
2023-12-26
By invitation
Chemotherapy-immunotherapy-based Split-course Adaptive Hypofractionated Radiotherapy for Extensive-stage SCLC
NCT06816966Small-cell Lung Cancer
Fujian Medical University Union Hospital
Phase 2
35
Fuzhou
2023-12-26
Recruiting
Application Value of Whole-procedure Optimization for Catheter Ablation of Atrial Fibrillation
NCT06145906Atrial Fibrillation
Henan Provincial People's Hospital
Observational
400
Zhengzhou
2023-12-26
Recruiting
A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients
NCT06155084Metastatic Castration-resistant Prostate Cancer
Hinova Pharmaceuticals Inc.
Phase 1/2
84
Hefei, Beijing, Chongqing, Xiamen, Lanzhou, Guangzhou, Guiyang, Zhengzhou
2023-12-26
Recruiting
Feasibility Study of Deep Learning-based MDixon Quant for Quantitative Assessment of Chemotherapy-induced Fatty Liver
NCT06735118Non-Alcoholic Fatty Liver Disease
Yunnan Cancer Hospital
Not applicable
120
Kunming
2023-12-25
Recruiting
Safety and Efficacy of Anti-FcRL5 CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma (R/R MM)
NCT06196255Multiple Myeloma
Xuzhou Medical University
Phase 1/2
20
Xuzhou
2023-12-25
Recruiting
The Efficacy and Safety of IBI363 in Solid Tumors
NCT06081907Advanced Solid Tumor
Hunan Province Tumor Hospital
Phase 1/2
430
Changsha
2023-12-25
Active, closed
Study of Human Bone Marrow Mesenchymal Stem Cells in APAP
NCT06111846Autoimmune Pulmonary Alveolar Proteinosis
Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd.
Phase 2
10
Beijing
2023-12-25
Recruiting
Wuhan High Myopia Study
NCT06162234High Myopia
Renmin Hospital of Wuhan University
Observational
1,000
Wuhan
2023-12-25
Recruiting
A Study of QLG1074 Combined With Background Therapy in Subjects With Active Lupus Nephritis
NCT06406205Lupus Nephritis
Qilu Pharmaceutical Co., Ltd.
Phase 3
270
Bengbu, Bozhou, Hefei, Beijing, Fuzhou, Dalian, Shanghai, Changzhi
2023-12-25
Recruiting
An Open Phase I Clinical Trial of SHR-1826 for Injection in Patients With Advanced Solid Tumors
NCT06094556Advanced Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1
240
Guangzhou
2023-12-25
Recruiting
M108 Plus CAPOX Versus Placebo Plus CAPOX as First-line Treatment for Claudin (CLDN) 18.2-Positive, HER2-Negative, PD-L1 CPS<5, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma.
NCT06177041Locally Advanced Unresectable or Metastatic Gastric Cancer, Locally Advanced Unresectable or Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
FutureGen Biopharmaceutical (Beijing) Co., Ltd
Phase 3
486
Beijing
2023-12-25
Recruiting
Sintilimab in Combination with Cetuximab and Chemotherapy As First-line Treatment for RAS/BRAF Wild-type Advanced Colorectal Cancer
NCT06776757Metastatic Colorectal Cancer
Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center
Phase 1/2
30
Shenzhen
2023-12-25
Recruiting
MRE for Assessment of Histopathological Growth Patterns in Colorectal Liver Metastases
NCT06208397Metastatic Colorectal Cancer
Shengjing Hospital
Observational
50
Shenyang
2023-12-24
Recruiting
Perioperative Chemotherapy Combined With Serplulimab or Placebo for pMMR Locally Advanced Gastric Adenocarcinoma (FOCUS-05)
NCT05872685Adenocarcinoma of the Stomach, Adenocarcinoma of Esophagogastric Junction, Proficient Mismatch Repair
Yu jiren
Phase 2
314
Hangzhou, Lishui, Ningbo, Taizhou
2023-12-24
Recruiting
Swartz Sheath With Angioplasty Guidewire-Assisted Technique for Patent Foramen Ovale Closure (STAGE-PFO)
NCT06793969Patent Oval Foramen
RenJi Hospital
Not applicable
120
Shanghai
2023-12-24
Recruiting
Study on the Value of Three DWI Scanning Sequences in Staging of Gastric Cancer
NCT06735105Gastric Cancer
Yunnan Cancer Hospital
Not applicable
129
Kunming
2023-12-23
Recruiting
Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine
NCT06184542Diphtheria, Tetanus, Pertussis
Institute of Medical Biology, Chinese Academy of Medical Sciences
Phase 1
460
Dazhou, Yibin
2023-12-23
Recruiting
A Study of Adebrelimab in Combination With Apatinib Gemcitabine and Cisplatin in Biliary Tract Malignancies
NCT06181032Biliary Tract Malignancies
First Affiliated Hospital of Fujian Medical University
Phase 1
35
Fuzhou
2023-12-23
Active, closed
Spectacle Films Utilising S.T.O.P.ยฎ Technology for Slowing Down Myopia Progression in Children
NCT06137560Myopia
nthalmic Pty Ltd
Not applicable
210
Tianjin, Shanghai
2023-12-22
Recruiting
Phase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate Cancer
NCT06139575Prostate Cancer
Bivision Pharmaceuticals, Inc.
Phase 1/2
90
Hefei, Beijing, Fuzhou, Guangzhou, Zhengzhou, Wuhan, Suzhou, Wuxi
2023-12-22
Active, closed
Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis๏ผšContezolid, Delamanid and Bedaquiline Cohort
NCT06081361Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis
Beijing Chest Hospital
Phase 3
186
Beijing, Changsha, Hefei, Jiamusi, Shandong, Xi'an, Xinxiang, Shijiazhuang
2023-12-22
Recruiting
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
NCT06119581Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
Eli Lilly and Company
Phase 3
1,264
Beijing, Changchun, Changsha, Changzhou, Chengdu, Fuzhou, Guangzhou, Haikou
2023-12-21
Active, closed
TPF Concurrent Chemo-radiotherapy Plus Immunotherapy for Local Advanced Esophageal Squamous Cell Carcinoma
NCT06401447Esophageal Squamous Cell Carcinoma
Fudan University
Not applicable
50
Shanghai
2023-12-21
Recruiting
PrevaLence of Albuminuria in Patients With CARdiovascular Disease and Type 2 Diabetes Mellitus in China: a National Cross-sectional Study
NCT06336239Cardiovascular Disease, Type 2 Diabetes Mellitus
Beijing Anzhen Hospital
Observational
3,000
Beijing, Chongqing, Haidong, Guangzhou, Shijiazhuang, Luoyang, Yongcheng, Zhengzhou
2023-12-21
Active, closed
A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naรฏve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)
NCT06140836Carcinoma, Non-Small-Cell Lung
Bristol-Myers Squibb
Phase 3
190
Beijing, Chongqing, Xiamen, Guangzhou, Nanning, Harbin, Zhengzhou, Wuhan
2023-12-21
Recruiting
Immunogenicity and Safety of Diphtheria, Tetanus, Pertussis (DTaP) Vaccine in 3-month-old Infants
NCT06344065Healthy Volunteers
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Phase 3
1,584
Nanning
2023-12-21
Recruiting
Study on the Improvement of Myocardial Microcirculation After Acute Anterior Myocardial Infarction
NCT06154395Intravascular Imaging and Microvascular Obstruction
Harbin Medical University
Not applicable
90
Harbin
2023-12-20
Active, closed
Factor XI inhibiTion for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
NCT06180889Knee Arthroplasty, Total
Suzhou Alphamab Co., Ltd.
Phase 2
241
Shanghai
2023-12-20
Recruiting
Efficacy and Safety of Combined With Immunotherapy After Induction Therapy With Chemotherapy and Targeted Therapy in the First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer
NCT06176885Colorectal Cancer
yue junhan
Phase 2
36
Jinhua
2023-12-20
Recruiting
Myocardial Stiffness Evaluation in Patients With Heart Failure With Preserved Ejection Fraction
NCT06196086Heart Failure With Preserved Ejection Fraction
Haiyan Wang
Observational
438
Jinan
2023-12-20
By invitation
The Construction and Effect Verification of a Deep Learning-based Automated Semantic Segmentation Model for Medical Imaging
NCT06864702Artificial Intelligence (AI), Deep Learning, Laparoscopic Surgery
Zhujiang Hospital
Not applicable
220
Guangzhou
2023-12-20
Recruiting
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
NCT06150157Neoplasms
Janssen Research & Development, LLC
Phase 1
300
Beijing, Tianjin
2023-12-20
Recruiting
RCT on Intralesional Rituximab Injection Versus ISRT in Ocular Adnexal MALT Lymphoma
NCT06190301Primary Ocular Adnexal MALT Lymphoma
Zhongshan Ophthalmic Center, Sun Yat-sen University
Not applicable
108
Guangzhou
2023-12-20
Recruiting
A Study of TAVO412 in Patients with Cancer (TAVO412)
NCT06761651Cancer
Tavotek Biotherapeutics
Phase 1
50
Chongqing, Xiamen, Guangzhou, Zhengzhou, Wuhan, Jinan
2023-12-20
Not yet open
Perioperative Immunotherpay Versus Adjuvant Immunotherapy for Resectable Non-small Cell Lung Cancer
NCT06109402Stage II-IIIB(N2) Non-small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China
Phase 2
160
Shanghai
2023-12-20
Recruiting
The Preliminary Safety and Efficacy of RRG001 After Vitrectomy in Subjects With Proliferative Diabetic Retinopathy (PDR)
NCT06412224PDR - Proliferative Diabetic Retinopathy
Li Xiaorong
Phase EARLY_PHASE1
6
Tianjin
2023-12-20
Not yet open
Umbilical Cord Mesenchymal Stem Cells for the Repair of Large Area Burn Wounds
NCT06122532Large Area Burns
ShiCang Yu
Not applicable
20
Chongqing
2023-12-20
Active, closed
Observational Study to Evaluate the Effect and Safety of Selumetinib in Pediatric Patients With NF1-PNs
NCT06175637Neurofibroma, Plexiform
AstraZeneca
Observational
409
Beijing, Chongqing, Lanzhou, Guangzhou, Shenzhen, Nanning, Guiyang, Shijiazhuang
2023-12-20
Recruiting
Efficacy and Safety of Sirolimus-Coated Spiral Balloon for Coronary Bifurcation Lesions
NCT06618248Coronary Bifurcation Lesion
Dongguan TT Medical
Not applicable
280
Beijing
2023-12-20
Recruiting
Global Trial in APG2575 for Patients With CLL/SLL
NCT06104566CLL/SLL
Ascentage Pharma Group Inc.
Phase 3
400
Hefei, Beijing, Fuzhou, Foshan, Guangzhou, Nanning, Zhengzhou, Wuhan
2023-12-20
Recruiting
Clinical Study of HRS-8080 in Combination With Dalpiciclib Isethionate Tablets in Patients With Unresectable or Metastatic Breast Cancer
NCT06167694Unresectable or Metastatic Breast Cancer
Shandong Suncadia Medicine Co., Ltd.
Phase 1/2
146
Beijing, Guangzhou
2023-12-20
Rows per page Showing 14001–14100 of 19052
Previous 139 140 141 142 143 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=141

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.